0.8(top 50%)
impact factor
1.5K(top 20%)
papers
14.0K(top 20%)
citations
41(top 20%)
h-index
0.8(top 50%)
impact factor
1.5K
all documents
14.9K
doc citations
58(top 20%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | Fibromuscular dysplasia | Current Treatment Options in Cardiovascular Medicine | 2005 | 149 |
2 | Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment | Current Treatment Options in Cardiovascular Medicine | 2014 | 141 |
3 | Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits? | Current Treatment Options in Cardiovascular Medicine | 2016 | 135 |
4 | Psychosocial Stress and Cardiovascular Disease | Current Treatment Options in Cardiovascular Medicine | 2019 | 113 |
5 | Infectious Aortitis | Current Treatment Options in Cardiovascular Medicine | 2005 | 100 |
6 | Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations | Current Treatment Options in Cardiovascular Medicine | 2017 | 97 |
7 | Extended Reality in Medical Practice | Current Treatment Options in Cardiovascular Medicine | 2019 | 97 |
8 | Hypertrophic Cardiomyopathy | Current Treatment Options in Cardiovascular Medicine | 2002 | 84 |
9 | Ventricular septal defect | Current Treatment Options in Cardiovascular Medicine | 1999 | 81 |
10 | Current management of thoracic outlet syndrome | Current Treatment Options in Cardiovascular Medicine | 2009 | 81 |
11 | High output cardiac failure | Current Treatment Options in Cardiovascular Medicine | 2001 | 80 |
12 | The role of angiogenesis in damage and recovery from ischemic stroke | Current Treatment Options in Cardiovascular Medicine | 2007 | 80 |
13 | Cardiovascular Complications Associated With Novel Cancer Immunotherapies | Current Treatment Options in Cardiovascular Medicine | 2017 | 75 |
14 | The nature of hand motor impairment after stroke and its treatment | Current Treatment Options in Cardiovascular Medicine | 2007 | 73 |
15 | Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond | Current Treatment Options in Cardiovascular Medicine | 2017 | 69 |
16 | Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment | Current Treatment Options in Cardiovascular Medicine | 2018 | 69 |
17 | The “Extreme Exercise Hypothesis”: Recent Findings and Cardiovascular Health Implications | Current Treatment Options in Cardiovascular Medicine | 2018 | 68 |
18 | Cardiovascular disease: Optimal approaches to risk factor modification of diet and lifestyle | Current Treatment Options in Cardiovascular Medicine | 2006 | 65 |
19 | Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment | Current Treatment Options in Cardiovascular Medicine | 2018 | 65 |
20 | Vitamin D and Cardiovascular Disease | Current Treatment Options in Cardiovascular Medicine | 2012 | 64 |
21 | Improving poststroke recovery: Neuroplasticity and task-oriented training | Current Treatment Options in Cardiovascular Medicine | 2009 | 59 |
22 | Evaluation and Management of Cardiac Tumors | Current Treatment Options in Cardiovascular Medicine | 2018 | 58 |
23 | Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions | Current Treatment Options in Cardiovascular Medicine | 2018 | 58 |
24 | Median arcuate ligament syndrome | Current Treatment Options in Cardiovascular Medicine | 2008 | 56 |
25 | Arterial Thrombosis in Patients with Cancer | Current Treatment Options in Cardiovascular Medicine | 2018 | 56 |
26 | Artificial Intelligence in Cardiovascular Medicine | Current Treatment Options in Cardiovascular Medicine | 2019 | 56 |
27 | Advanced Neuroimaging of Cerebral Small Vessel Disease | Current Treatment Options in Cardiovascular Medicine | 2017 | 55 |
28 | Thrombi of Different Pathologies: Implications for Diagnosis and Treatment | Current Treatment Options in Cardiovascular Medicine | 2010 | 51 |
29 | White Matter Disease as a Biomarker for Long-Term Cerebrovascular Disease and Dementia | Current Treatment Options in Cardiovascular Medicine | 2014 | 49 |
30 | Cardiomyopathy caused by antineoplastic therapies | Current Treatment Options in Cardiovascular Medicine | 2001 | 47 |
31 | Strategies to Reduce Dietary Sodium Intake | Current Treatment Options in Cardiovascular Medicine | 2012 | 47 |
32 | Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia | Current Treatment Options in Cardiovascular Medicine | 2017 | 46 |
33 | Left ventricular thrombus | Current Treatment Options in Cardiovascular Medicine | 2001 | 45 |
34 | Cardiac effects of stroke | Current Treatment Options in Cardiovascular Medicine | 2004 | 45 |
35 | Cardiac Arrest: the Changing Incidence of Ventricular Fibrillation | Current Treatment Options in Cardiovascular Medicine | 2015 | 45 |
36 | Hippo/Yap Signaling in Cardiac Development and Regeneration | Current Treatment Options in Cardiovascular Medicine | 2016 | 45 |
37 | Digital Health Technologies to Promote Lifestyle Change and Adherence | Current Treatment Options in Cardiovascular Medicine | 2017 | 45 |
38 | Pericardial Disease in Cancer Patients | Current Treatment Options in Cardiovascular Medicine | 2018 | 45 |
39 | Future G protein-coupled receptor targets for treatment of heart failure | Current Treatment Options in Cardiovascular Medicine | 2009 | 44 |
40 | Omega-3 Fatty Acids for Cardiovascular Disease Prevention | Current Treatment Options in Cardiovascular Medicine | 2010 | 44 |
41 | Transcatheter Mitral Valve Planning and the Neo-LVOT: Utilization of Virtual Simulation Models and 3D Printing | Current Treatment Options in Cardiovascular Medicine | 2018 | 44 |
42 | Management of constrictive pericarditic in the 21st century | Current Treatment Options in Cardiovascular Medicine | 2007 | 43 |
43 | Mesenchymal Stem Cell Therapy for Cardiac Repair | Current Treatment Options in Cardiovascular Medicine | 2014 | 43 |
44 | Cardiac Stem Cell Therapy for Cardiac Repair | Current Treatment Options in Cardiovascular Medicine | 2014 | 43 |
45 | Thrombolytic therapy in acute ischemic stroke | Current Treatment Options in Cardiovascular Medicine | 2003 | 42 |
46 | Cardiotoxicity of Immune Checkpoint Inhibitors | Current Treatment Options in Cardiovascular Medicine | 2019 | 42 |
47 | Update on the Biology and Treatment of Lymphedema | Current Treatment Options in Cardiovascular Medicine | 2012 | 41 |
48 | Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options | Current Treatment Options in Cardiovascular Medicine | 2016 | 41 |
49 | Acute myocarditis in children: Current concepts and management | Current Treatment Options in Cardiovascular Medicine | 2009 | 40 |
50 | Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect? | Current Treatment Options in Cardiovascular Medicine | 2014 | 40 |